P1784

Pentoxifylline

solid

• Synonim(y): 3,7-Dimethyl-1-(5-oxohexyl)xanthine, Trental
• Wzór empiryczny (zapis Hilla): C₁₃H₁₈N₄O₃
• Numer CAS: 6493-05-6
• Masa cząsteczkowa: 278.31
• Numer WE: 229-374-5
• Numer MDL: MFCD00063379
• Kod UNSPSC: 41106305
• Identyfikator substancji w PubChem: 24278190
• NACRES: NA.77

Właściwości

• Formularz: solid
• Poziom jakości: 100
• kolor: white
• rozpuszczalność: H₂O: ≥43 mg/mL, colorless to almost colorless
• inicjator: Sanofi Aventis
• ciąg SMILES: CN1C=NC2C1C(=O)N(CCCCC(C)=O)C(=O)N2C
• InChI: 1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8,10-11H,4-7H2,1-3H3
• Klucz InChI: MQGNNJQTNFHNHK-UHFFFAOYSA-N
• informacje o genach: human ... ADORA2B(136) , LITAF(9516) , PDE4B(5142) , TNF(7124) ; rat ... Tnf(24835)

Opis

Zastosowanie

Pentoxifylline has been used:

• used in the combinatorial treatment with itraconazole for paracoccidioidomycosis (PCM)
• to treat harvested sperms to check the effect of ′pentoxifylline exposed sperms′ in the contribution of embryonic growth
• to intrathecally inject female and male mice to investigate whether astrocytes and microglia could be causally involved in the maintenance of pain-like behaviour

Działania biochem./fizjol.

Pentoxifylline (PTX) is considered as a nonspecific phosphodiesterase inhibitor. It possesses rheologic properties. Pentoxifylline is used to treat peripheral vascular disease. It has the ability to block the phosphorylation of I kappa B-alpha (IĸBα) in serines 32 and 36.

Phosphodiesterase inhibitor; inhibits synthesis of tumor necrosis factor α (TNF-α).

Cechy i korzyści

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the Histamine Synthesis and Metabolism and Phosphodiesterases pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS07
• Hasło ostrzegawcze: Warning
• Zwroty wskazujące rodzaj zagrożenia: H302,H362
• Zwroty wskazujące środki ostrożności: P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313
• Klasyfikacja zagrożeń: Acute Tox. 4 Oral - Lact.
• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Środki ochrony indywidualnej: dust mask type N95 (US), Eyeshields, Gloves